Global Depression Therapeutics Market is estimated to be US$ 17.49 billion by 2030 with a CAGR of 3.0% during the forecast period

Download Sample

Published Date: September 2021

Global Depression Therapeutics Market accounted for US$ 13.7 billion in 2020 and is estimated to be US$ 17.49 billion by 2030 and is anticipated to register a CAGR of 3.0%. Antidepressants, sometimes known as depression pills, are a class of medications taken by patients to treat mental illnesses such as depression and social anxiety.Depression and other mental illnesses are characterised by a lack of pleasant emotions, mood fluctuations, and a variety of physical, cognitive, emotional, and behavioural symptoms. Seasonal affective disorder, anxiety, and dysthymia can all be alleviated with the use of antidepressants. Depression is a mental illness marked by a lack of pleasant feelings, a persistently low mood, and a slew of cognitive, physical, behavioural, and emotional signs and symptoms. It is diagnosed by recognising the symptoms and reviewing the patient's medical history. It is then treated with antidepressants, which regulate the patient's mood and emotions by balancing the activity of neurotransmitters in the brain, such as serotonin.

The report “Global Depression Therapeutics Market, By Drug Type (Selective Serotonin Reuptake Inhibitors (SSRIs), Selective Norepinephrine Reuptake Inhibitors (SNRIs), and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and By Region (North America, Latin America, Europe, Middle East, Asia Pacific, and Africa) - Trends, Analysis and Forecast till 2030”

Key Highlights:

In 2021, Happify Health launched a prescription digital therapeutic (DTx) that can assist the treatment of people with both major depressive disorder and generalised anxiety disorder in the US market.

Analyst View:

The market is driven by an increase in the prevalence of depression, an increase in the geriatric population, and the discovery of novel approaches for the creation of medications with fewer adverse effects. Furthermore, rising knowledge of the disease condition and essential therapeutic demands, as well as an increase in the number of people suffering from stress, could propel the antidepressant medications industry forward. However, the market is projected to be hampered by the drug's poor efficacy and safety profiles, preference for non-pharmacological therapy, and a rise in the number of antidepressant patent expirations, resulting in a weak pipeline.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Depression Therapeutics Market, By Drug Type (Selective Serotonin Reuptake Inhibitors (SSRIs), Selective Norepinephrine Reuptake Inhibitors (SNRIs), and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and By Region (North America, Latin America, Europe, Middle East, Asia Pacific, and Africa) - Trends, Analysis and Forecast till 2030”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Depression-Therapeutics-Market-By-26

Key Market Insights from the report:

Global Depression Therapeutics Market accounted for US$ 13.7 billion in 2020 and is estimated to be US$ 17.49 billion by 2030 and is anticipated to register a CAGR of 3.0%. Global Depression Therapeutics Market is segmented by Drug type, Distribution, and region.

By Drug type, the Global Depression Therapeutics Market is segmented into Selective Serotonin Reuptake Inhibitors (SSRIs), Selective Norepinephrine Reuptake Inhibitors (SNRIs), and Others
By Distribution Channel, the Global Depression Therapeutics Market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
By region, the Global Depression Therapeutics Market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa.

Competitive Landscape:

The key players operating in the global depression therapeutics market includes Pfizer, Inc., Eli Lilly and Company, AstraZeneca Plc, Allergan Plc, GlaxoSmithKline Plc, Intellipharmaceutics International, Inc., Takeda Pharmaceutical Company Limited, H.Lundbeck A/S, Otsuka Holdings Co.,Ltd., Apotex, Inc., Shionogi & Co. Ltd., Zhejiang Hua Hai Pharmaceutical Co., Ltd., and Chengdu Kanghong Pharmaceutical Group Co.,Ltd.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period